Automated method for the determination of vitamin D3 hydroxymetabolites in serum

An almost automated method for the determination of hydroxymetabolites of vitamin D₃ (cholecalciferol) in human serum is reported. The method consists of three steps: 1) a batch liquid–liquid extraction step with 2-propanol and hexane, and drying of the extract and reconstitution with phosphate buffer. 2) A cleanup and preconcentration step based on solid-phase extraction using Prospekt equipment, with CN group cartridges and elution with the chromatographic mobile phase. 3) A chromatographic step for individual separation of the target analytes starting with a 90:10 methanol–water mixture, then a linear gradient to obtain 100% methanol; followed by photometric detection. The method provides a linear range between 1.0 and 100 ng mL^–1 for 24,25-(OH)₂ vitamin D₃ and for 25-(OH)₂ vitamin D₃, and between 1.5 and 100 ng mL^–1 for 1,25-(OH) vitamin D₃, with correlation coefficients ranging between 0.993 and 0.987, repeatability between 1.9% and 4.8% and within-laboratory reproducibility between 2.8% and 8.8%.     

The Measurement of Nanogram Quantities of Vitamin D3

Abstract

An isotope dilution method is described for the measurement of nanogram quantities of vitamin D₃ (cholecalciferol). Use is made of the Diels -Alder reaction between vitamin D₃ and tetracyanoethylene.

Increasing quantities of exogeneous vitamin D₃ added to a standard reaction mixture of ¹⁴C-labelled vitamin D₃ and tetracyanoethylene produced a decrease in the ratio of reacted to unreacted vitamin D₃. The ratio (y) was measured by radio-scanning of an eluted thin-layer chromatogram, and quantitation of added vitamin D₃ was thereby achieved.     

Determination of Vitamin D3 and 25-Hydroxyvitamin D3 Using Liquid Chromatography with Amperometric Detection

Abstract

The electrochemical behaviour of vitamin D₃ and 25-hydroxyvitamin D₃ (25-OH D₃) in a high performance liquid chromatography system using amperometric detection is described. Separation is carried out using a C18 reversed-phase column and the optimum mobile phase was a 0.1 M LiClO₄ solution in methanol-water (97:3, v/v) at a flow rate of 1.25 ml/min. 25-OH D₃ and vitamin D₃ were eluted with good resolution at retention times of 3 and 6 minutes respectively, and determined by amperometric detection with a glassy carbon electrode at + 1.050 V (vs Ag/AgCl). Calibration graphs for both substances showed good linearity when amounts of vitamin D₃ between 18 and 312 ng and 27 and 412 ng of 25-OH D₃ were injected. Detection limits of 8 ng (vitamin D₃) and 25 ng (25-OH D₃); relative standard deviations of 3.2% (vitamin D₃) and 5.8% (25-OH D₃) were obtained.     

Enhanced sensitivity by laser-induced fluorescence for the determination of calcitriol and other vitamin D3 metabolites in plasma

Summary A sensitive method for the determination of hydroxymetabolites of vitamin D₃, parficularly calcitriol (1,25-(OH)₂-D₃), in human plasma is reported. The method is based on the use of laser-induced fluorescence detection as an alternative to conventional fluorimetry in an integrated cleanup/preconcentration, HPLC separation and post-column derivatization system. The derivatization step is based on a dehydration reaction which takes place in secosteroid structures at high temperature in a strong-acid medium. A LOD of 0.01 pg mL⁻¹ (SNR=3) was obtained for each analyte with a linear dynamic range over 4 order of magnitude with excellent regression coefficients (≥0.9922) in all cases. The precision was studied at two concentration levels and the RSDs values (for n=5) were acceptable (between 2.6 and 4.7%). The method was also checked by applying it to human plasma spiked with the target analytes and excellent recoveries were obtained. This is the first time that these species have been determined at the sub-pg mL⁻¹ level.     

Metabolic profiling of major vitamin D metabolites using Diels–Alder derivatization and ultra-performance liquid chromatography–tandem mass spectrometry

Biologically active forms of vitamin D are important analytical targets in both research and clinical practice. The current technology is such that each of the vitamin D metabolites is usually analyzed by individual assay. However, current LC-MS technologies allow the simultaneous metabolic profiling of entire biochemical pathways. The impediment to the metabolic profiling of vitamin D metabolites is the low level of 1α,25-dihydroxyvitamin D₃ in human serum (15–60 pg/mL). Here, we demonstrate that liquid–liquid or solid-phase extraction of vitamin D metabolites in combination with Diels–Alder derivatization with the commercially available reagent 4-phenyl-1,2,4-triazoline-3,5-dione (PTAD) followed by ultra-performance liquid chromatography (UPLC)–electrospray/tandem mass spectrometry analysis provides rapid and simultaneous quantification of 1α,25-dihydroxyvitamin D₃, 1α,25-dihydroxyvitamin D₂, 24R,25-dihydroxyvitamin D₃, 25-hydroxyvitamin D₃ and 25-hydroxyvitamin D₂ in 0.5 mL human serum at a lower limit of quantification of 25 pg/mL. Precision ranged from 1.6–4.8 % and 5–16 % for 25-hydroxyvitamin D₃ and 1α,25-dihydroxyvitamin D₃, respectively, using solid-phase extraction. Electronic supplementary material  The online version of this article (doi:) contains supplementary material, which is available to authorized users.     

Facile Construction of the 7,8‐Olefin Linkage in Vitamin D3: A Practical Synthesis Benefiting the Vitamin D3 Analog Study

Abstract

A facile procedure for construction of the 7,8‐olefin linkage in vitamin D₃ is described. Treatment of a mixture of A‐ring phosphine oxide and CD‐ring ketone in THF with lithium hexamethyldisilazide (LHMDS) at ?20°C followed by gradual heating to 50°C gives the key intermediate of vitamin D₃ analogs in excellent yield. This simplified procedure makes possible small‐scale synthesis benefiting the vitamin D₃ analog study.     

Vitamin D analysis in plasma by high performance liquid chromatography (HPLC) with C(30) reversed phase column and UV detection--easy and acetonitrile-free

Two physiologically important forms of vitamin D exist: vitamin D₂ and vitamin D₃, which by liver based hydroxylase enzymes are converted to 25-hydroxyvitamin D₂ and 25-hydroxyvitamin D₃, respectively. These hydroxylated metabolites of vitamin D are measured in plasma to assess the vitamin D status of animals and humans. Therefore cheap and reliable analytical methods are very much in demand in nutritional and physiological research. After saponification and extraction of plasma or serum samples the current method uses reverse phase high performance liquid chromatography on a C₃₀ column and with UV detection at 265 nm for quantifying vitamin D₂, vitamin D₃, 25-hydroxyvitamin D₂, and 25-hydroxyvitamin D₃. The method proved versatile with respect to plasma lipid content, sample amount, and plasma concentration of the vitamin D metabolites as it was tested using plasma from six different species: cattle, pigs, poultry, mink, horses, and humans. In cattle plasma recoveries were between 86.6 and 101.0%, within day error between 0.9 and 5.9%, and between day error between 0.2 and 1.7%. However, depending on species and sample amount error percentages varied. When running the method on standard reference material^® 972 “Vitamin D in human serum” from the National Institute of Standards and Technology (NIST) (Gaithersburg, USA) the results for 25-hydroxyvitamin D₂ and 25-hydroxyvitamin D₃ concentrations were within the boundaries provided by NIST, reflected by Z-scores between 0.1 and 0.9.     

A pharmacophore model for dopamine D4 receptor antagonists

A pharmacophore model for dopamine D₄ antagonists has been developed on the basis of a previously reported dopamine D₂ model. By using exhaustive conformational analyses (MM3^* force field and the GB/SA hydration model) and least-squares molecular superimposition studies, a set of eighteen structurally diverse high affinity D₄ antagonists have successfully been accommodated in the D₄ pharmacophore model. Enantioselectivities may be rationalized by conformational energies required for the enantiomers to adopt their proposed bioactive conformations. The pharmacophore models for antagonists at the D₄ and D₂ receptor subtypes have been compared in order to get insight into molecular properties of importance for D₂/D₄ receptor selectivity. It is concluded that the bioactive conformations of antagonists at the two receptor subtypes are essentially identical. Receptor essential volumes previously identified for the D₂ receptor are shown to be present also in the D₄ receptor. In addition, a novel receptor essential volume in the D₄ receptor, not present in the D₂ receptor, has been identified. This feature may be exploited for the design of D₄ selective antagonists. However, it is concluded that the major determinant for D₂/D₄ selectivity is the nature of the interactions between the receptor and aromatic ring systems. The effects of the electronic properties of these ring systems on the affinities for the two receptor subtypes differ substantially.     

Synthesis of 2α- and 2β-substituted-14-epi-previtamin D3 and their genomic activity

2α- and 2β-Substituted analogs of 14-epi-previtamin D₃ were synthesized and isolated after thermal isomerization of 14-epi-vitamin D₃ triene at 80 °C. The VDR binding affinity and transactivation activity of osteocalcin promoter in HOS cells were tested, and the 2α-methyl-substituted analog was found to have greater genomic activity than 14-epi-previtamin D₃. We found that modification at the C2 position of the seco-steroidal skeleton afforded interesting effects for biological genomic activity for the previtamin D form as well as the natural vitamin D form.     

The Spectrophotometric Determination of Vitamin a Using Iodine

Abstract

Methods are described for the spectrophotometric determination of vitamin A (0.15–12.5 μg) using iodine as the chromogenic reagent. The reaction is most sensitive in chloroform. Vitamin D₂ and ß-carotene do not interfere if the analysis is carried out in 1, 2 -dichloroethane.     

Quantitative Determination of Octamethylcyclotetrasiloxane (D4) in Extracts of Biological Matrices by Gas Chromatography-Mass Spectrometry

Abstract

A method was developed and validated to measure octamethylcyclotetrasiloxane (D₄)^? quantitatively by gas chromatography-mass spectrometry (GC-MS) at low level in extracts of several biological matrices that include plasma, liver, lung, feces and fat from rats. The key to the successful determination lay in the use of extracts dried with anhydrous magnesium sulfate. This was necessary in view of the propensity of the methyl siloxane based GC-stationary phase to generate D₄ by its reaction with water present in the extracts. To enable quantiiation of D₄ at parts per billion (μg/L) levels, the base ion m/z 281 resulting from the loss of a methyl group from the parent molecule was selected for monitoring by SIM mode in GC-MS. The recovery of D₄ from any of the biological matrices was determined to be greater than 90% in three extractions. The D₄ response for the standards in GC-MS was linear (R² > 0.9900) and reproducible at concentrations ranging from 1—16,000 ng D₄/g solvent. Precision was less than 5%.     

Study of blood collection and sample preparation for analysis of vitamin D and its metabolites by liquid chromatography–tandem mass spectrometry

The analysis of vitamin D status, with special emphasis on 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, is gaining interest in clinical studies due to the classical and non-classical effects attributed to this prohormone. In this research, the influence of the two steps preceding determination (viz. sample collection and preparation) on the quantitative analysis of vitamin D and its more important metabolites has been studied. Two preparation approaches, deproteination and solid-phase extraction (SPE), have been evaluated in terms of sensitivity to delimit their application, thus establishing that detection of 1,25-dihydroxyvitamin D cannot be addressed by protein precipitation. Concerning sample collection, serum and plasma reported high accuracy (above 83.3%) for vitamin D and metabolites, while precision, expressed as relative standard deviation, was below 12.9% for all analytes in both samples. Statistical analysis revealed that serum and plasma provided similar physiological levels for vitamin D₃, 24,25-dihydroxyvitamin D₃ and 25-hydroxyvitamin D₃, while significantly different levels were obtained for 1,25-dihydroxyvitamin D₃, always higher in plasma than in serum. Sample collection and treatment have proved to be significant in the analysis of vitamin D and its relevant metabolites.     

Use of packed-fiber solid-phase extraction for sample clean-up and preconcentration of vitamin B_(12) before determination

A rapid and simple preconcentration step applying packed-fiber solid-phase extraction columns has been investigated to vitamin B_(12).The extraction performance of the new method was investigated preliminarily on vitamin functional drink.The analysis used a reversed-phase C_(18) column,with a photo-diode array detector at 220 nm.The samples were preconcentrated with packed-fiber solid-phase extraction columns.Good linearity was observed in vitamin functional drink.The repeatability of extraction performa...     

Zur Epoxidation der Δ 7-Doppelbindung in Vitamin D3 Röntgenstrukturanalyse des 4-Phenyl-1,2,4-triazolin-3,5-dion-Addukts — eine Strukturrevision

Epoxidation of vitamin D₃ withMCPBA yields exclusively the 7,8-monooxirane. Its 7R, 8R stereochemistry was established by X-ray analysis of thePTAD-adduct-derivative. This result corrects the stereochemical assignment in a previous publication⁷.

     

Liquid chromatography–tandem mass spectrometric method for the determination of salivary 25-hydroxyvitamin D<Subscript>3</Subscript>: a noninvasive tool for the assessment of vitamin D status

A sensitive liquid chromatography–electrospray ionization–tandem mass spectrometric (LC–ESI–MS/MS) method for the determination of 25-hydroxyvitamin D₃ [25(OH)D₃] in human saliva has been developed and validated. The saliva was deproteinized with acetonitrile, purified using a Strata-X cartridge, derivatized with a Cookson-type reagent, 4-phenyl-1,2,4-triazoline-3,5-dione (PTAD), and subjected to LC–MS/MS. The PTAD derivative was much more easily ionized in positive-ESI–MS and efficiently produced a characteristic product ion during MS/MS, compared to the intact 25(OH)D₃. Methylamine was used as the mobile phase additive, and also effectively enhanced the assay sensitivity. Quantification was based on selected reaction monitoring, and 25-hydroxyvitamin D₄ was used as the internal standard. This method allowed the reproducible and accurate quantification of salivary 25(OH)D₃ using a 1.0-ml sample, and the limit of quantitation for 25(OH)D₃ was 2.0 pg/ml. The applicability of the developed method for clinical studies was then examined. There was a positive linear relationship (r ² = 0.830) between the serum 25(OH)D₃ level, which is conventionally used as a means of assessing the vitamin D status, and the salivary 25(OH)D₃ level measured using the proposed method. The method also enabled the detection of the increase in the salivary 25(OH)D₃ level after the supplementation of vitamin D₃.     

Liquid-Solid Extraction of Vitamin D3 Metabolites from Plasma for Analysis by HPLC,GC/MS and Protein Binding Techniques

Abstract

Liquid-solid extraction of vitamin D₃ metabolites from human plasma using octadecylsilane bonded silica has been studied. Steroid-protein interactions were minimized by diluting the plasma (or serum) with two volumes of saline and passing the solution through the sorbent at 64°C. Highly purified secosteroid fractions were obtained by washing with aqueous methanol, drying the sorbent in situ with a stream of nitrogen for one minute and eluting with mixtures of hexane/chloroform. Recoveries of vitamin D₃ metabolites were essentially quantitative. Applications to the rapid analysis of 25-hydroxy- and 1α, 25-dihydroxy-vitamin D in plasma by high-performance liquid chromatography, gas chromatography-mass spectrometry or by a receptor protein assay are reported.     

Quercetin enhances vitamin D2 stability and mitigate the degradation influenced by elevated temperature and pH value

Vitamin D₂ (vit. D₂) is a nutraceutical essentially needed for good health. However, it is susceptible to oxygen and high temperature. The use of natural products such as bioflavonoids possessing anti-degradative effect of vit. D₂ degradation has not been described before. A combinational effect of vit. D₂ with quercetin showed a positive effect and inhibited vit. D₂ degradation when exposed to high temperature (50 ℃ and 75 ℃) at different time points. The results obtained revealed vit. D₂ degradation was drastically increased with longer incubation under thermal treatment. However, quercetin and vit. D₂ groups were able to significantly inhibit the degradation of vit. D₂ and stabilize it, evaluated through the retention percentage. We also exposed vit. D₂ at solutions with different pH values (1, 4, 5, 7, 10). Quercetin exerted vit. D₂ anti-degradation at different pH values as well as under thermal pressure at different time points. Conclusively, quercetin can be an effective way to reduce temperature and pH induced degradation of vit. D₂.     

Tetracyanonickelate compounds as sorptive materials and the substitution of their H2O content by D2O

The compounds NiNi(CN)₄·3,5H₂O and Ni(NH₃)₂Ni(CN)₄·H₂O have been studied to examine the possibility of substituting their H₂O or NH₃ content by D₂O. Contact with D₂O was performed after heating the compounds to several temperatures. Depending on the degree of decomposition of the original compounds different ranges of substitution were possible. In such manner the compounds NiNi(CN)₄·3,5D₂O, NiNi(CN)₄·5D₂O, Ni(NH₃)₂Ni(CN)₄·D₂O, and Ni(D₂O)₂Ni(CN)₄·D₂O were prepared and thermally they were less stable than the original ones. The substitution by D₂O is in agreement with the sorptive properties of the original tetracyanonickelate against different organic compounds using GC, since these could substitute the guest component and sometimes also the ligands during their decomposition.     

Über die Stereochemie der Bisoxirane aus den 4-N-Phenyl-triazolin-3,5-dion-addukten von Vitamin D3: Röntgenstrukturanalyse eines der Benzoylderivate

Summary Upon complete epoxidation of the vitamin D₃ 4-phenyltriazoline-3,5-dione adducts2 and3 withMCPBA, four diastereomeric bisoxiranes7, 8, 9, and10 were generated. The stereochemistry of all the chiral centers in these compounds has been established by chemical correlation with compounds of known stereochemistry and by single crystal X-ray structure determination of the benzoyl derivative10 b.

     

DSC study of the phase transitions in [Ni(D2O)6](ClO4)2 and [Ni(H2O)6](ClO4)2

DSC measurements were carried out for [Ni(H₂O)₆](ClO₄)₂ (sampleH) and [Ni(D₂O)₆](ClO₄)₂ (sampleD) in the temperature range 300–380 K. For both compounds two anomalies on the DSC curves were detected. The results for sampleH are compared to those previously obtained using adiabatic calorimetry method. For both compounds studied in this work the high-temperature transition appears at the same temperature while the low-temperature one is shifted towards higher temperatures in sampleD. Disorder connected with H₂O or D₂O groups is suggested in the intermediate phase between the low- and high-temperature transitions.